ReviewThe FEBS journal2023

Therapeutic applications of CRISPR/Cas9 gene editing technology for the treatment of ocular diseases.

Yogapriya Sundaresan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.